Pharmacy

Trump tweets gratitude to Pfizer, Novartis for pausing price hikes

President Donald Trump on July 19 thanked Pfizer and Novartis for holding off on raising the prices of their medications. By Mackenzie Bean - 7/19/18
FDA 'breakthrough' drug evidence often limited, study finds

The 46 medicines that received approval through 2017 as part of the FDA's Breakthrough Therapy program are often sent to patients without sufficient evidence to back them or prove their benefits, a study published in JAMA found. By Megan Knowles - 7/19/18
FDA commissioner criticizes big pharma for stalling introduction of cheaper drugs

FDA Commissioner Scott Gottlieb, MD, slammed drugmakers, accusing them of using "gaming tactics" to stall biosimilars, a move that cost the U.S. healthcare system billions of dollars last year, Bloomberg reports. By Alia Paavola - 7/19/18

Joining Pfizer, Novartis freezes price hikes in US

After its rival Pfizer was slammed on Twitter by President Donald Trump for raising the price of several drugs, Swiss pharmaceutical company Novartis announced it will halt drug price increases in the U.S. for the remainder of the year, according to Bloomberg. By Alia Paavola - 7/18/18
Novartis' net income surges to $7.7B in Q2

Swiss pharmaceutical giant Novartis saw its second-quarter net income surge to $7.77 billion, up from $1.98 billion in the second quarter of 2017. By Alia Paavola - 7/18/18
Cancer drugs help boost J&J to $20.8B in Q2 revenue

Johnson & Johnson beat revenue and earnings estimates for the second quarter of 2018 as sales of pharmaceuticals surged 20 percent year-over-year, CNBC reports. By Alia Paavola - 7/18/18
5 latest drug, medical device recalls

Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety. By Alia Paavola - 7/17/18

Pfizer urged to 'permanently roll back prices'

Six days after Pfizer announced it would postpone price hikes, Sen. Tammy Baldwin, D-Wis., sent a letter to the company's CEO Ian Read calling on the pharmaceutical manufacturer to institute permanent price rollbacks, according to The Hill. By Leo Vartorella - 7/17/18
Several common heart drugs recalled in US: 5 things to know

The FDA recalled several medications containing valsartan, an active ingredient used to control blood pressure and prevent heart failure, July 13, a week after 22 other countries issued a recall. By Alia Paavola - 7/16/18
Drug shortages task force in works at FDA

In an effort to combat shortages of medically necessary products, the FDA will create the Drug Shortages Task Force, the agency announced July 12. By Alia Paavola - 7/16/18
FDA warns consumers who buy medications online about international scam

The FDA issued a warning July 13 to notify consumers who purchase medications online or by phone about a recent scam in which criminals pose as agency officials. By Julie Spitzer - 7/16/18

J&J hit with $4.7B verdict in St. Louis talcum powder-cancer case

A jury in St. Louis awarded $550 million in actual damages and $4.14 billion in punitive damages in a lawsuit against pharmaceutical giant Johnson & Johnson, claiming its talcum powder caused ovarian cancer, according to the St. Louis Post-Dispatch. By Alia Paavola - 7/16/18
Novartis bows out of antibiotic research, cuts 140 jobs in California

Novartis is shutting down antibacterial and antiviral research at its campus in Emeryville, Calif., which will result in a loss of 140 jobs, according to Bloomberg. By Alia Paavola - 7/13/18
8 lesser-known facts about Pfizer

Many people are familiar with Pfizer and its wide range of products including Advil, Viagra, Xanax and Robitussin, but hidden from the public are several interesting facts about the company's history. By Alia Paavola - 7/12/18
Pfizer delays some drug price hikes after Trump's criticism

Pharmaceutical giant Pfizer agreed to postpone some drug price increases one day after President Donald Trump slammed the company on Twitter, saying it should be "ashamed" of the decision. By Alia Paavola - 7/11/18
Pfizer to split into 3 units, including hospital business — 5 notes

Drugmaker Pfizer revealed July 11 the company plans to reorganize into three businesses, effective at the beginning of the company's 2019 fiscal year. By Alyssa Rege - 7/11/18
Packaging concerns force Novartis, Sandoz to recall 12 drugs

Drugmakers Novartis and Sandoz recalled 12 medications July 6 because the packaging does not meet childproofing standards, CNN reports. By Alia Paavola - 7/10/18
Pfizer stock value dips after Trump's tweet

Pfizer shares sank after President Donald Trump blasted the pharmaceutical giant on Twitter for increasing the price of 100 drugs and treatments, according to The Wall Street Journal. By Alia Paavola - 7/10/18
Trump calls out Pfizer for price hikes

President Donald Trump on July 9 called out several drugmakers, including Pfizer, for making drug price hikes earlier this month, reports Reuters. By Mackenzie Bean - 7/10/18
10 most popular prescriptions in June

Here is a list of the 10 most popular prescriptions in the U.S. for June 2018, according to GoodRx. The list tallies the 10 medications most frequently filled at pharmacies by reviewing a large sample of claims. By Alia Paavola - 7/9/18

Page 1 of 50

«
Prev
1
2
3
4
5
6
7
8
9
10
Next
»

Top 40 Articles from the Past 6 Months